Novo Nordisk A/S (B Shares) ADRhedged (NVOH)

Assets	$3.66M
Expense Ratio	0.19%
PE Ratio	10.29
Forward PE	n/a
Shares Out	170,001
Dividend	$1.56 (7.06%)
Ex-Dividend Date	Sep 16, 2026
Payout Frequency	Quarterly
Payout Ratio	72.67%

Volume	1,897
Open	22.18
Previous Close	21.62
Day's Range	22.18 - 22.20
52-Week Low	19.00
52-Week High	34.36
Beta	n/a
Holdings	6
Inception Date	Jan 2, 2025

About NVOH

Fund Home Page

The Novo Nordisk A/S (B Shares) ADRhedged (NVOH) is an exchange-traded fund that mostly invests in health care equity. The fund provides exposure to Novo Nordisk A/S (B Shares) ADR, while using swaps to hedge daily currency fluctuations. The fund aims to provide the total return performance of Novo Nordisk A/S (B Shares), in its local market, to US investors. NVOH was launched on Jan 2, 2025 and is issued by ADRhedged.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSE Arca
• Ticker Symbol: NVOH
• ETF Provider: ADRhedged

Top Holdings

Name	Symbol	Weight
U.S. Dollar	n/a	187.17%
Danish Krone	n/a	93.60%
Novo Nordisk A/S	NVO	93.10%
Dreyfus Trsry Securities Cash Mgmt	n/a	6.28%
Danish Krone	n/a	-93.60%
U.S. Dollar	n/a	-186.55%

Dividend History

Ex-Dividend	Amount	Pay Date
Sep 16, 2026	$0.0298	Sep 23, 2026
Jun 16, 2026	$0.7667	Jun 23, 2026
Mar 16, 2026	$0.275	Mar 23, 2026
Dec 16, 2025	$0.488	Dec 24, 2025
Sep 16, 2025	$0.1657	Sep 23, 2025

Performance

NVOH had a total return of -24.16% in the past year, including dividends. Since the fund's inception, the average annual return has been -34.44%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error